Long-term nephrotoxicity in adult survivors of childhood cancer

Clin J Am Soc Nephrol. 2013 Jun;8(6):922-9. doi: 10.2215/CJN.09980912. Epub 2013 Feb 14.

Abstract

Background and objectives: Because little is known about long-term treatment-related nephrotoxicity, the aim was to determine risk factors for renal impairment long after childhood cancer treatment.

Design, setting, participants, & measurements: Data from 763 adult childhood cancer survivors (414 men) were obtained during regular visits at the late-effects clinic between 2003 and 2009. Median follow-up time was 18.3 years (range=5.0-58.2). Glomerular function was assessed by estimated GFR (using the Modification of Diet in Renal Disease formula), urinary albumin creatinine ratio, and tubular function by urinary β2-microglobulin creatinine ratio. The association with treatment factors was analyzed with covariance analysis for estimated GFR and logistic regression for urinary albumin and urinary β2-microglobulin creatinine ratios.

Results: Survivors treated with nephrectomy and abdominal irradiation had significantly lower estimated GFR than survivors not treated with nephrectomy/abdominal irradiation (estimated mean=90 ml/min per 1.73 m(2) versus 106, P<0.001). Estimated GFR was significantly lower in survivors after treatment with high-dose ifosfamide (88 versus 98, P=0.02) and high-dose cisplatin (83 versus 101, P=0.004) compared with survivors not treated with these regimen. Nephrectomy combined with abdominal radiotherapy (odds ratio=3.14, 95% confidence interval=1.02; 9.69) and high-dose cisplatin (odds ratio=5.19, 95% confidence interval=1.21; 22.21) was associated with albuminuria. High-dose ifosfamide (odds ratio=6.19, 95% confidence interval=2.45; 15.67) was associated with increased urinary β2-microglobulin creatinine ratio. Hypertension was present in 23.4% of survivors and 31.4% of renal tumor survivors.

Conclusions: Treatment with unilateral nephrectomy, abdominal radiotherapy, cisplatin, and ifosfamide was associated with lower estimated GFR. Persisting tubular damage was related to ifosfamide treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Albuminuria / etiology
  • Antineoplastic Agents / adverse effects*
  • Biomarkers / urine
  • Chemotherapy, Adjuvant
  • Cisplatin / adverse effects
  • Creatinine / urine
  • Cross-Sectional Studies
  • Female
  • Glomerular Filtration Rate / drug effects
  • Glomerular Filtration Rate / radiation effects
  • Humans
  • Ifosfamide / adverse effects
  • Kidney Diseases / diagnosis
  • Kidney Diseases / etiology*
  • Kidney Diseases / physiopathology
  • Kidney Diseases / urine
  • Kidney* / drug effects
  • Kidney* / physiopathology
  • Kidney* / radiation effects
  • Kidney* / surgery
  • Logistic Models
  • Male
  • Middle Aged
  • Neoplasms / therapy*
  • Nephrectomy / adverse effects*
  • Odds Ratio
  • Radiation Injuries / diagnosis
  • Radiation Injuries / etiology*
  • Radiation Injuries / physiopathology
  • Radiation Injuries / urine
  • Radiotherapy, Adjuvant / adverse effects
  • Retrospective Studies
  • Risk Factors
  • Survivors*
  • Time Factors
  • Young Adult
  • beta 2-Microglobulin / urine

Substances

  • Antineoplastic Agents
  • Biomarkers
  • beta 2-Microglobulin
  • Creatinine
  • Cisplatin
  • Ifosfamide